Policy & Research

Shaping bipartisan public policy

AMMA's policy priorities focus on creating a fair and competitive environment for domestic producers — ensuring a secure and reliable supply chain for critical medical supplies.

Submissions, Letters & Research

Regulatory comments, open letters & white papers

Written Submission – Investigation No. 332-609, Effects on the U.S. Economy of Revoking China’s Permanent Normal Trade Relations Status May 28, 2026 Comments on Advance Notice of Proposed Rulemaking – Medicare Program; Ensuring Safety Through Domestic Security with Made in America Personal Protective Equipment (PPE) and Essential Medicine Procurement by Medicare Participating Hospitals (CMS-1516-ANPRM) May 28, 2026 Comments of the American Medical Manufacturers Association on the Initiation of Section 301 Investigations: Acts, Policies, and Practices of Certain Economies Relating to Structural Excess Capacity and Production in Manufacturing Sectors (Docket No. USTR-2026-0067) May 28, 2026 Comments of the American Medical Manufacturers Association on the Initiation of Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure to Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced With Forced Labor (Docket No. USTR-2026-0133) May 28, 2026 AMMA Response to Request for Comment on Section 232 Investigation of Imports of PPE Nov 6, 2025 AMMA Congressional Open Letter 2025 Jan 23, 2025 AMMA Administration Open Letter 2025 Jan 23, 2025 AMMA Public USTR Comments on Section 301 Tariffs Jul 1, 2024 AMMA 301 Modifications Letter - REDACTED (1) AMMA White Paper: The State of the PPE Industry in the U.S. Apr 24, 2024 A Reshoring Movement Spurred by the Pandemic As supply chains fractured in 2020, U.S. companies and buyers quickly realized that the predominant outsourcing of entire industries and product groupings might not be the… Administration Open Letter Feb 7, 2024 Administration Open Letter Congressional Open Letter Feb 6, 2024 Click to read the letter 115+ Organizations Call on Congress to Reauthorize PAHPA Dec 28, 2023 S. Senator Bill Cassidy, M.D. (R-LA), ranking member of the Senate Health, Education, Labor and Pensions (HELP) Committee, released a statement highlighting the 137 organizations who have called on Congress to… AMERICA’S PPE OPPORTUNITY Oct 30, 2023 BUILDING SELF-RELIANCE THROUGH DOMESTIC PPE PRODUCTION The COVID-19 Pandemic exposed the USA’s reliance on foreign manufacturing of essential PPE. Before the pandemic, 90%+ PPE supplies were manufactured in Southeast… Open Letter: Three Years Later, Substantial Work Remains to Strengthen America's Domestic PPE Supply Chain Oct 25, 2023 A Bipartisan Commitment to America's Resilience Oct 25, 2023 A dedicated White House Office of Pandemic Preparedness is necessary and a strategic imperative for the United States. That’s why AMMA greets today’s announcement with such hope and optimism. We hope this office works… Memo of Findings Oct 25, 2023 Domestic sourcing strategy brings balance to healthcare provider supply chains Oct 25, 2023 4 Ways USAID Could Play a Critical Role in Projecting US Power Through American Manufacturing Oct 25, 2023 Away They Go - A Bipartisan Senate Delegation Heads to China Oct 25, 2023 Takeaway: We urge our leaders to protect America’s ability to remain competitive and resilient in the face of public health challenges Background: Senate Majority Leader Chuck Schumer will lead a bipartisan delegation…